GSK3B and colorectal cancer: PKCβII potentiates tumor growth (e.g., in gastric and colorectal cancers) by activating the glycogen synthase kinase 3 beta (GSK3β) signaling axis, which enhances cellular proliferation and invasiveness [79, 80].